Cargando…

Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease

BACKGROUND: Fecal lactoferrin (FL) levels may mirror drug-induced changes in inflammation in ulcerative colitis and Crohn disease in a timely way and could be used to assess loss of response (LOR) to biologics. METHODS: This study is a retrospective outcome review in 61 patients on adalimumab, infli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sorrentino, Dario, Gray, James M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Research Articles - Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314109/ https://www.ncbi.nlm.nih.gov/pubmed/33501943 http://dx.doi.org/10.1093/ibd/izaa348

Ejemplares similares

Erratum to: Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease
Publicado: (2021)

Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
por: Rubio, Marrieth G, et al.
Publicado: (2019)

Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD
por: Buderus, Stephan, et al.
Publicado: (2015)

Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis
por: Zhou, Xing-lu, et al.
Publicado: (2014)

Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis
por: Chen, Rirong, et al.
Publicado: (2023)

Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial
por: El Amrousy, Doaa, et al.
Publicado: (2022)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes
por: Vieira, Andrea, et al.
Publicado: (2009)

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments
por: Lee, Scott D., et al.
Publicado: (2021)

Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases
por: Zhao, Yuge, et al.
Publicado: (2020)

Correlation of rapid point-of-care vs send-out fecal calprotectin monitoring in pediatric inflammatory bowel disease
por: Rodriguez, Alexis, et al.
Publicado: (2017)

Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent
por: Bosch, Sofie, et al.
Publicado: (2022)

Lactoferrin: Lactoferrin: a modulator of immune and inflammatory responses
por: Legrand, D., et al.
Publicado: (2005)

Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy
por: Moastafa, Tarek M., et al.
Publicado: (2014)

Comparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children
por: Prata, Mara de Moura Gondim, et al.
Publicado: (2016)

The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases
por: Galgut, Bianca J., et al.
Publicado: (2018)

The Functional Role of Lactoferrin in Intestine Mucosal Immune System and Inflammatory Bowel Disease
por: Liu, Ning, et al.
Publicado: (2021)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

Fecal Incontinence in Inflammatory Bowel Disease
por: Kamal, Natasha, et al.
Publicado: (2021)

Lactoferrin in Aseptic and Septic Inflammation
por: Lepanto, Maria Stefania, et al.
Publicado: (2019)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
por: Truta, Brindusa
Publicado: (2022)

Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
por: Wei, Shu Chen
Publicado: (2016)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease
por: Boicean, Adrian, et al.
Publicado: (2023)

Assessing Histological Inflammatory Activity in Patients With Ulcerative Colitis: A Diagnostic Accuracy Study Testing Fecal Biomarkers Lactoferrin and Calprotectin
por: Langhorst, Jost, et al.
Publicado: (2020)

THE INVOLVEMENT OF LACTOFERRIN IN THE HYPOSIDEREMIA OF ACUTE INFLAMMATION
por: van Snick, Jacques L., et al.
Publicado: (1974)

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
por: Kittanakom, Saranya, et al.
Publicado: (2017)

Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
por: Liu, Fang, et al.
Publicado: (2020)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Updates in therapeutic drug monitoring in inflammatory bowel disease
por: Lodhia, Nilesh, et al.
Publicado: (2022)

Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
por: Albader, Farah, et al.
Publicado: (2021)

Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments
por: Pan, Yu, et al.
Publicado: (2021)

Fecal Myeloperoxidase as a Biomarker for Inflammatory Bowel Disease
por: Hansberry, David R, et al.
Publicado: (2017)

Fecal Serine Protease Profiling in Inflammatory Bowel Diseases
por: Jablaoui, Amin, et al.
Publicado: (2020)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Lactoferrin in a Context of Inflammation-Induced Pathology
por: Kruzel, Marian L., et al.
Publicado: (2017)

Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study
por: Kwapisz, Lukasz, et al.
Publicado: (2015)

Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases
por: Martins, Camilla de Almeida, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2gri365po1fehkb7jiujnc617